CHE · NYSE · Medical - Care Facilities

Chemed (CHE)

Operates hospice care and plumbing-services businesses through VITAS and Roto-Rooter.

$501.84
vs last close+2.22 (+0.44%)
Loading prices…

Chemed CorporationCHE
Health Care

Runs VITAS hospice and palliative care and Roto-Rooter plumbing and restoration services. The two businesses operate separately under a decentralized holding-company model.

VITAS provides hospice and palliative care through clinicians, aides, social workers, clergy and volunteers. Roto-Rooter serves residential and commercial customers with plumbing, drain cleaning, excavation and water-restoration services. The operations address distinct care and property-service needs.

The businesses operate separately under a decentralized holding-company model, with few shared sales, marketing or purchasing functions. Corporate staff directs long-term planning, major capital allocation, investments, financial reporting, tax, legal matters and key operating-executive selection. Its corporate office is responsible for both oversight and resource-allocation functions. The structure depends on two distinct service businesses rather than an integrated platform.

Company facts

CEOKevin J. McNamara
ListedMay 3, 1973
ExchangeNYSE
HeadquartersCincinnati, OH
CountryUnited States
Employees15,695
CIK0000019584
ISINUS16359R1032

Market cap$6.53B
EPS (ttm)$19.92
P/E (ttm)25.08
ROE29.5%
P/B7.86
P/S2.52
Dividend yieldDiv yield0.50%
Beta0.03vs XLV 0.37

Price target$554.00+10.9%Average of 9 analysts
ConsensusHold6 of 9 analysts
Ratings

Target rangeAs of Sep 21, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Feb 27, 2026RBC CapitalDowngrade
Rating: Outperform
Rating: Sector Perform
Jan 22, 2026JefferiesDowngrade
Rating: BuyTarget: $550
Rating: HoldTarget: $475
Sep 2, 2025JefferiesUpgrade
Rating: HoldTarget:
Rating: BuyTarget: $550

Next report
Oct 27, 26
in 35 days
EPS estimate
$6.39
Revenue estimate
$684.5M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26Oct '26
Reported$6.83$5.63$4.27$5.27$6.42$5.65$6.06Pending
Estimate$6.78$5.55$4.78$5.39$7.02$5.30$5.60$6.39
Surprise+0.7%+1.4%−10.7%−2.2%−8.5%+6.6%+8.2%

RevenueReportedEstimate

Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26Oct '26
Reported$640.0M$646.9M$618.8M$624.9M$639.3M$657.5M$673.3MPending
Estimate$636.1M$641.8M$631.1M$659.0M$659.1M$649.8M$665.0M$684.5M
Surprise+0.6%+0.8%−2.0%−5.2%−3.0%+1.2%+1.2%
Estimate$6.39
ReportedDue Oct 27, 2026
Estimate$684.5M
ReportedDue Oct 27, 2026
View details

Debt to equity39.60%
Current ratio91.10%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$606.2M$640.0M$646.9M$618.8M$624.9M$639.3M$657.5M$673.3M
Net income$75.8M$90.3M$71.8M$52.5M$64.2M$76.8M$66.3M$67.7M
Net margin12.5%14.1%11.1%8.5%10.3%12.0%10.1%10.1%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income$92.2M$113.9M$94.8M$68.1M$74.8M$100.7M$84.6M$89.2M
YoY growth+6.1%+2.2%+31.0%−22.7%−18.9%−11.6%−10.7%+31.0%

Balance sheet, Jun 30, 2026Cash & short-term investments $40.2M · Total debt $329.1M · Total assets $1.58B · Shareholders' equity $830.5M

Revenue
$673.3M
Operating income
$89.2M
Net income
$67.7M
View details

Dividend yield
0.50%
Next ex-date
Nov 17, 26
estimated · in 56 days
Annual dividend
$2.50
per share
Schedule
Quarterly
4 payments a year

HistoryDividendAnnual yield

Nov '24Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26
Dividend$0.50$0.50$0.50$0.60$0.60$0.60$0.60$0.70
Annual yield0.32%0.35%0.35%0.49%0.51%0.48%0.55%0.48%
Ex-dateNov 18Feb 24May 29Aug 11Nov 17Feb 23May 28Aug 17
Payment dateDec 6Mar 14Jun 17Aug 29Dec 5Mar 13Jun 16Sep 3
View details

Institutions≥ 97.27%12.71M shares
537 holders · as of Jun 30, 2026 · largest filers only
Insiders1.10%144.0K shares
13 holders · as of Sep 21, 2026
Other≤ 1.63%212.7K shares
remainder

13.07M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

This quarter's institutional total failed a plausibility check; shown: the 99 largest filers, so at least this.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
BlackRock, Inc.Institution
11.36%1.48Mas of Jun 30, 2026
AQR Capital Management LLCInstitution
7.44%972,474as of Jun 30, 2026
Vanguard Portfolio Management LLCInstitution
6.02%787,068as of Jun 30, 2026
Riverbridge Partners LLCInstitution
5.85%764,047filed Jan 24, 2017
Vanguard Capital Management LLCInstitution
4.62%604,420as of Jun 30, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Sep 18, 2026Kevin J. Mcnamaradirector, officer: president and CEO−2,000$501.40
Aug 21, 2026Spencer S. Leeofficer: executive vice president−1,000$541.04
Aug 21, 2026Kevin J. Mcnamaradirector, officer: president and CEO−2,000$541.16
Aug 3, 2026Kevin J. Mcnamaradirector, officer: president and CEO−2,000$539.51
Jul 31, 2026Patrick P. Gracedirector−190$532.00
View details

Compare

CompanyPriceChange
Chemed$501.84+0.44%$6.53B25.119.52.5+8.8%
UnitedHealth Group$376.14−0.38%$342.88B24.317.60.8+0.4%
Addus HomeCare$116.31+0.82%$2.15B20.216.11.5+8.0%
The Pennant Group$39.37+1.05%$1.35B43.327.11.2+35.8%
BrightSpring Health Services$56.63+1.38%$10.96B41.727.70.8+23.0%
Aveanna Healthcare$13.28−1.16%$2.93B10.615.51.1+13.7%
Frontdoor$79.09−0.80%$5.60B21.116.02.6+4.5%
Median22.716.91.2+10.9%